Terms: = Endocrine gland cancer AND TG, Thyroglobulin AND Treatment
1558 results:
1. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
2. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
4. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
5. False diagnosis of recurrent thyroid carcinoma: the importance of testing for heterophile antibodies.
Guastapaglia L; Chiamolera MI; Viana Lima Junior J; Ferrer CMF; Godoy Viana L; Veiga Chang C; Andrade Siqueira R; Monteiro Barros Maciel R; Henriques Vieira JG; Biscolla RPM
Arch Endocrinol Metab; 2024 Mar; 68():e230115. PubMed ID: 38456952
[TBL] [Abstract] [Full Text] [Related]
6. Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid cancer.
Sun D; Zhang X; Sun Y; Mu Z; Wang H; Zhang Y; Liang J; Lin Y
Endocr Pract; 2024 May; 30(5):456-464. PubMed ID: 38447630
[TBL] [Abstract] [Full Text] [Related]
7. Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients.
Chantadisai M; Wongwijitsook J; Ritlumlert N; Rakvongthai Y
Sci Rep; 2024 Feb; 14(1):5001. PubMed ID: 38424177
[TBL] [Abstract] [Full Text] [Related]
8. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
[TBL] [Abstract] [Full Text] [Related]
9. Correlation between remnant thyroid gland I-131 uptake and serum thyroglobulin levels: can we rely on I-131 whole body scans?
Hwang SH; Jo K; Cha J; Kang CG; Wang J; Cho H; Kang WJ; Cho A
Cancer Imaging; 2024 Jan; 24(1):21. PubMed ID: 38291522
[TBL] [Abstract] [Full Text] [Related]
10. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
11. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
12. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid cancer in the West of Scotland: A Retrospective Analysis.
Graham K; Tough F; Belikova H; Wotherspoon I; Colville D; Reed N
Endocr Pract; 2024 Apr; 30(4):327-332. PubMed ID: 38184240
[TBL] [Abstract] [Full Text] [Related]
13. Risk factors for recurrence of differentiated thyroid carcinoma in children and adolescents: A retrospective cohort study.
Jia S; Tang D; Peng W
Medicine (Baltimore); 2023 Dec; 102(50):e36585. PubMed ID: 38115329
[TBL] [Abstract] [Full Text] [Related]
14. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: a systematic review and network meta-analysis.
Li X; Ding W; Zhang H
Front Endocrinol (Lausanne); 2023; 14():1256209. PubMed ID: 38111707
[TBL] [Abstract] [Full Text] [Related]
15. Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.
Shi H; Yang B; Feng JI; Li JH; Cheng X; Li YJ; Fu Y; Xu XD; Qian LH; Tang LJ; Liu W
Nucl Med Commun; 2024 Mar; 45(3):169-174. PubMed ID: 38095140
[TBL] [Abstract] [Full Text] [Related]
16. The Prognostic Power of Preablation Stimulated thyroglobulin in Children With Differentiated Thyroid cancer.
Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
[TBL] [Abstract] [Full Text] [Related]
17. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract] [Full Text] [Related]
18. Wire-guided localization and surgical resection of non-palpable recurrent of thyroid carcinoma: A STROBE-compliant, retrospective cohort study.
Carrillo JF; Carrillo LC; Ramírez-Ortega MC; Pacheco-Bravo I; Ramos-Mayo A; Oñate-Ocaña LF
Eur J Surg Oncol; 2024 Jan; 50(1):107306. PubMed ID: 38048725
[TBL] [Abstract] [Full Text] [Related]
19. Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study.
Barreto L; Ferreira DCG; Corrente JE; Soares CSP; Oliveira CC; Terra SA; Moriguchi SM; Koga KH; Tagliarini JV; da Silva Mazeto GMF
Hormones (Athens); 2024 Mar; 23(1):97-106. PubMed ID: 38015413
[TBL] [Abstract] [Full Text] [Related]
20. Challenges and current advances in the methodology of thyroglobulin measurements.
Đorić I; Šelemetjev S
Bioanalysis; 2024 Jan; 16(1):49-60. PubMed ID: 37991211
[TBL] [Abstract] [Full Text] [Related]
[Next]